<p>DEPs between the patients with stage 3A, 3B and 4 Coats’ disease and the controls (<i>p</i> < 0.05).</p
<p>Panel A: DEGs associated with phospholipidosis under all conditions (single dose at 3, 6, 9 and 2...
<p>Pathological feauters and normalized <i>DEK</i> expression levels of FFPE samples of controls (1–...
<p>Comparison of demographic and pathologic factors between patients with positive and negative prox...
<p>The numbers in parentheses indicate the total number of DCPs in stage 3A, stage 3B and stage 4, w...
<p>A, relationship between DEGs at 6, 9 and 11 dpi; B, relationship between DEGs at 13 and 16 dpi; C...
<p>The incidence of pathological changes in target organs in different treatments at D15 and D42.</p
<p>DEGs significantly downregulated in the three CNS disorders and upregulated in the three Cancer t...
<p>DEGs significantly upregulated in the three CNS disorders and downregulated in the three Cancer t...
<p>Significant cytokines at different phases of illness when compared to the controls.</p
<p>Patients’ disease characteristics andfrequencies-percentages of the examined markers—N (%).</p
<p>The distribution of decorin levels between the normal control patients and the patients with NDMM...
Characteristics of patients with neurodegenerative diseases and their matched controls at the index ...
(A) Number of DEGs at 10 hpi and 72 hpi compared to 0 hpi time-point in HW2004. (B) Venn diagram rep...
<p>Burden of disease between patients with PID, before and after the treatment with IVIG, matched he...
<p>Occurrence of Separate Conditions among Participants with one or more Diseases (n = 213) at Inclu...
<p>Panel A: DEGs associated with phospholipidosis under all conditions (single dose at 3, 6, 9 and 2...
<p>Pathological feauters and normalized <i>DEK</i> expression levels of FFPE samples of controls (1–...
<p>Comparison of demographic and pathologic factors between patients with positive and negative prox...
<p>The numbers in parentheses indicate the total number of DCPs in stage 3A, stage 3B and stage 4, w...
<p>A, relationship between DEGs at 6, 9 and 11 dpi; B, relationship between DEGs at 13 and 16 dpi; C...
<p>The incidence of pathological changes in target organs in different treatments at D15 and D42.</p
<p>DEGs significantly downregulated in the three CNS disorders and upregulated in the three Cancer t...
<p>DEGs significantly upregulated in the three CNS disorders and downregulated in the three Cancer t...
<p>Significant cytokines at different phases of illness when compared to the controls.</p
<p>Patients’ disease characteristics andfrequencies-percentages of the examined markers—N (%).</p
<p>The distribution of decorin levels between the normal control patients and the patients with NDMM...
Characteristics of patients with neurodegenerative diseases and their matched controls at the index ...
(A) Number of DEGs at 10 hpi and 72 hpi compared to 0 hpi time-point in HW2004. (B) Venn diagram rep...
<p>Burden of disease between patients with PID, before and after the treatment with IVIG, matched he...
<p>Occurrence of Separate Conditions among Participants with one or more Diseases (n = 213) at Inclu...
<p>Panel A: DEGs associated with phospholipidosis under all conditions (single dose at 3, 6, 9 and 2...
<p>Pathological feauters and normalized <i>DEK</i> expression levels of FFPE samples of controls (1–...
<p>Comparison of demographic and pathologic factors between patients with positive and negative prox...
DOI
Add to ORKG